Contributions of connectional pathways to shaping Alzheimer’s disease pathologies

Four important imaging biomarkers of Alzheimer's disease, namely grey matter atrophy, glucose hypometabolism and amyloid-β and tau deposition, follow stereotypical spatial distributions shaped by the brain network of structural and functional connections. In this case-control study, we combined several predictors reflecting various possible mechanisms of spreading through structural and functional pathways to predict the topography of the four biomarkers in amyloid-positive patients while controlling for the effect of spatial distance along the cortex. For each biomarker, we quantified the relative contribution of each predictor to the variance explained by the model. We also compared the contribution between apolipoprotein E-ɛ4 carriers and non-carriers. We found that topological proximity to areas of maximal pathology through the functional connectome explained significant parts of variance for all biomarkers and that functional pathways totalized more than 30% of contributions for hypometabolism and amyloid load. By contrast, atrophy and tau load were mainly predicted by structural pathways, with major contributions from inter-regional diffusion. The ɛ4 allele modulated contributions to the four biomarkers in a way consistent with compromised brain connectomics in carriers. Our approach can be used to assess the contribution of concurrent mechanisms in other neurodegenerative diseases and the possible modifying impact of relevant factors on this contribution.

Authors

Institutions

Publication Details

Journal
Brain Communications
Published
2024-12-24
DOI
https://doi.org/10.1093/braincomms/fcae459
Citations
3
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.98

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contributions of connectional pathways to shaping Alzheimer’s disease pathologies

Marc Dhénain, Denis Vivien, Gaël Chételat, Salma Bougacha et al.
3 citations
Brain Communications
Alzheimer's disease research and treatments
0.98
article

Contributions of connectional pathways to shaping Alzheimer’s disease pathologies

Marc Dhénain, Denis Vivien, Gaël Chételat, Salma Bougacha, Brigitte Landeau, Siya Sherif, Alexandre Bejanin, Mikaël Naveau, Daniel Roquet, Ashish Raj, Elise Saul
article en
3 citations

Abstract

Four important imaging biomarkers of Alzheimer's disease, namely grey matter atrophy, glucose hypometabolism and amyloid-β and tau deposition, follow stereotypical spatial distributions shaped by the brain network of structural and functional connections. In this case-control study, we combined several predictors reflecting various possible mechanisms of spreading through structural and functional pathways to predict the topography of the four biomarkers in amyloid-positive patients while controlling for the effect of spatial distance along the cortex. For each biomarker, we quantified the relative contribution of each predictor to the variance explained by the model. We also compared the contribution between apolipoprotein E-ɛ4 carriers and non-carriers. We found that topological proximity to areas of maximal pathology through the functional connectome explained significant parts of variance for all biomarkers and that functional pathways totalized more than 30% of contributions for hypometabolism and amyloid load. By contrast, atrophy and tau load were mainly predicted by structural pathways, with major contributions from inter-regional diffusion. The ɛ4 allele modulated contributions to the four biomarkers in a way consistent with compromised brain connectomics in carriers. Our approach can be used to assess the contribution of concurrent mechanisms in other neurodegenerative diseases and the possible modifying impact of relevant factors on this contribution.

Brain CommunicationsVol. 7(1)
Universitat Autònoma de Barcelona (ES), Centre National de la Recherche Scientifique (FR), Inserm (FR), University of California, San Francisco (US), Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR), Université Paris-Saclay (FR), Hospital de Sant Pau (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Normandie Université (FR), Direction de la Recherche Fondamentale (FR), Centre Hospitalier Universitaire de Caen Normandie (FR), CEA Paris-Saclay (FR), Biomedical Research Institute (US), Cyceron (FR), Physiopathologie et imagerie des troubles neurologiques, Université de Caen Normandie (FR)
Fondation Vaincre Alzheimer, European Commission, Institut National de la Santé et de la Recherche Médicale, Association France Alzheimer, Fondation Bettencourt Schueller, FONDATION ALZHEIMER, Région Normandie, Instituto de Salud Carlos III
Good health and well-being
Openalex Percentile: Top 22%
Alzheimer's disease research and treatments
0.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.